Zheyong Li

Sir Run Run Shaw Hospital

Papers

4

Total Citations

68

H-Index

3

About

Dr. Zheyong Li is a pioneering surgeon at the forefront of minimally invasive hepatobiliary and pancreatic surgery, with a particular focus on robotic and remote surgical technologies. His major contributions include leading the PORTAL trial, a landmark multicenter phase III non-inferiority randomized controlled trial comparing robotic versus open pancreatoduodenectomy for pancreatic and periampullary tumors (44 citations), which aims to establish the role of robotics in complex pancreatic surgery. Dr. Li has also demonstrated the feasibility of ultra-remote surgery by successfully performing 5G remote robot-assisted hepatobiliary and pancreatic procedures (14 citations), a groundbreaking achievement that expands access to specialized surgical care. His work extends to innovative techniques such as repeated laparoscopic liver resection using ICG fluorescent imaging for recurrent liver cancer (7 citations) and comparative studies of robotic versus laparoscopic distal gastrectomy (3 citations). Through these contributions, Dr. Li is shaping the future of surgical oncology by integrating advanced robotics, real-time imaging, and telecommunication technologies to improve patient outcomes and redefine the boundaries of what is possible in hepatobiliary and pancreatic surgery.

Research Focus

Key Achievements

3
H-Index
4
Papers
68
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Robotic versus Open Pancreatoduodenectomy for Pancreatic and Periampullary Tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority randomized controlled trial
44 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 33
🏛 Institutions: Sir Run Run Shaw Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago